CLINICAL UPDATES Non-Hodgkin lymphoma

被引：92

作者：

Al-Naeeb, Anna Bowzyk ^{[1
]}

Ajithkumar, Thankamma ^{[2
]}

Behan, Sarah ^{[3
]}

Hodson, Daniel James ^{[3
,4
]}

机构：

[1] Bedford Hosp, Dept Oncol, Bedford, England

[2] Cambridge Univ Hosp NHS Trust, Dept Oncol, Cambridge, England

[3] Cambridge Univ Hosp NHS Trust, Dept Haematol, Cambridge, England

[4] Univ Cambridge, Wellcome Trust, Med Res Council, Stem Cell Inst, Cambridge, England

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2018年 / 362卷

关键词：

B-CELL LYMPHOMA; CHEMOTHERAPY PLUS RITUXIMAB; RANDOMIZED CONTROLLED-TRIAL; MALIGNANCY RESEARCH NETWORK; FOLLICULAR LYMPHOMA; ADVANCED-STAGE; OPEN-LABEL; HEMATOLOGICAL MALIGNANCY; 1ST-LINE TREATMENT; HIGH-RISK;

D O I：

10.1136/bmj.k3204

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页数：7

共 34 条

[1] Anticancer chemotherapy in teenagers and young adults: managing long term side effects [J].

Ahmad, Saif S. ;

Reinius, Marika A. V. ;

Hatcher, Helen M. ;

Ajithkumar, Thankamma V. .

BMJ-BRITISH MEDICAL JOURNAL, 2016, 354 :i4567

[2] Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma [J].

Al-Tourah, Abdulwahab J. ;

Gill, Karamjit K. ;

Chhanabhai, Mukesh ;

Hoskins, Paul J. ;

Klasa, Richard J. ;

Savage, Kerry J. ;

Sehn, Laurie H. ;

Shenkier, Tamara N. ;

Gascoyne, Randy D. ;

Connors, Joseph M. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (32) :5165-5169

[3]

[Anonymous], GLOBOCAN 2012 EST CA

[4] Rituximab versus a watch-and-wait approach in patients with advanced- stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial [J].

Ardeshna, Kirit M. ;

Qian, Wendi ;

Smith, Paul ;

Braganca, Nivette ;

Lowry, Lisa ;

Patrick, Pip ;

Warden, June ;

Stevens, Lindsey ;

Pocock, Christopher F. E. ;

Miall, Fiona ;

Cunningham, David ;

Davies, John ;

Jack, Andrew ;

Stephens, Richard ;

Walewski, Jan ;

Ferhanoglu, Burhan ;

Bradstock, Ken ;

Linch, David C. .

LANCET ONCOLOGY, 2014, 15 (04) :424-435

[5] Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial [J].

Ardeshna, KM ;

Smith, P ;

Norton, A ;

Hancock, BW ;

Hoskin, PJ ;

MacLennan, KA ;

Marcus, RE ;

Jelliffe, A ;

Hudson, GV ;

Linch, DC .

LANCET, 2003, 362 (9383) :516-522

[6] B-cell receptor pathway modulators in NHL [J].

Blum, Kristie A. .

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, :82-91

[7] Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: A randomized study from the Groupe D'Etude des Lymphomes Folliculaires [J].

Brice, P ;

Bastion, Y ;

Lepage, E ;

Brousse, N ;

Haioun, C ;

Moreau, P ;

Straetmans, N ;

Tilly, H ;

Tabah, I ;

SolalCeligny, P .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :1110-1117

[8] The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015 [J].

Brown, Katrina F. ;

Rumgay, Harriet ;

Dunlop, Casey ;

Ryan, Margaret ;

Quartly, Frances ;

Cox, Alison ;

Deas, Andrew ;

Elliss-Brookes, Lucy ;

Gavin, Anna ;

Hounsome, Luke ;

Huws, Dyfed ;

Ormiston-Smith, Nick ;

Shelton, Jon ;

White, Ceri ;

Parkin, D. Max .

BRITISH JOURNAL OF CANCER, 2018, 118 (08) :1130-1141

[9]

Cancer Research UK (CRUK), NONH LYMPH STAT

[10] Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study [J].

Casulo, Carla ;

Byrtek, Michelle ;

Dawson, Keith L. ;

Zhou, Xiaolei ;

Farber, Charles M. ;

Flowers, Christopher R. ;

Hainsworth, John D. ;

Maurer, Matthew J. ;

Cerhan, James R. ;

Link, Brian K. ;

Zelenetz, Andrew D. ;

Friedberg, Jonathan W. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (23) :2516-U55

← 1 2 3 4 →